PALB2 and breast neoplasm: Regarding PALB2 tumors, a studyconducted by Heikkinen et al.(2009) found that breast tumors arising in patients carrying aFinnish founder mutation in PALB2 (c.1592delT) are more likelyto have triple-negative phenotype when compared to non-PALB2mutation-associated BCs.